Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Part of paid clinical trials in Miami, Florida.

Sponsor
Columbia University
Study ID
NCT06601933
Phase
PHASE2
Status
Recruiting

Conditions

  • Cognitive Training
  • Mild Cognitive Impairment (MCI)

Eligibility Criteria

Sex
ALL
Age
55 Years - 89 Years
Healthy Volunteers
Not accepted

Interventions

  • Cognitive Training — OTHER
    Participants (n=240) will be randomized to high dose crosswords, low dose crosswords, and health education at 1:1:1 ratio, stratified by site, age (\< 70 and 70 years), and MCI status (early MCI and late MCI). In the two crossword puzzles conditions, after initial training to use the web-based platform, the participant will be assigned to do 12 weeks of crossword puzzles four times per week or 12 weeks of crossword puzzles once per week at home. After these 12 weeks, booster sessions will be either four or one 30-minute session(s) completed over 1 week. These booster sessions will occur at weeks 20, 32, 42, 52, 64, and 78. In-person assessments will occur at 0, 12, 32, 52, 78 weeks with one crossword puzzle session, which will count toward the booster session. Health education will involve reading chapters in a book on common illnesses and lifestyle, and a research staff member will review these chapters at the same assessment intervals as the crossword puzzles conditions.

Study Details

Effective, clinically meaningful treatments are lacking for patients with mild cognitive impairment (MCI), which is associated with increased risk of transition to dementia. Cognitive training represents an important therapeutic strategy. In a previous study, crossword puzzles were found to be superior to computerized cognitive training on the primary cognitive outcome and function with decreased brain atrophy. Building on these findings, this study will evaluate and compare the impact of high dose crosswords (4 puzzles per week) to low dose crosswords (1 puzzle per week) and a health education control group on the cognition and function of participants.

Key Dates

Start date
Dec 17, 2024
Status verified
Jun 2025
Primary completion
Feb 28, 2029
Completion
Feb 28, 2029

Study Design

Enrollment
240 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Placebo Comparator: Control
    This sample will receive health education. The participant will read chapters from the book, "Living a Healthy Life with chronic conditions," 5th edition, by K Lorig, D Laurent, V Gonzalez, D Sobel, M Minor and M Gecht-Silver, and review chapters with the unblinded study coordinator.
  • Active Comparator: Low Dose Crossword
    This sample will receive low dose crossword training with one crossword puzzle per week during the first 12 weeks on the Cognifit web-based platform. Subsequent booster sessions will occur at 20, 32, 42, 52, 64 and 78 weeks.
  • Active Comparator: High Dose Crossword
    This sample will receive high dose crossword training. This sample will receive high dose crossword training with four crossword puzzles per week during the first 12 weeks on the Cognifit web-based platform, followed by booster sessions at 20, 32, 42, 52, 64 and 78 weeks.

Primary Outcome Measure

Change in ADASCog-14 (14-item Alzheimer's Disease Assessment Scale - Cognitive subscale) [ Time Frame: Baseline, 78 weeks ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
University of Miami Miller School of MedicineMiamiFlorida33136
Sebastian Escarfuller
305-243-6489
Philip D Harvey, PhD (PRINCIPAL_INVESTIGATOR)
Columbia University Irving Medical CenterNew YorkNew York10032
Lola Nedic, BA
6467747202
Davangere P Devanand, MD, MBBS (PRINCIPAL_INVESTIGATOR)
Duke University Medical CenterDurhamNorth Carolina27710
Caroline Hellegers
919-681-3986
Murali Doraiswamy, MD (PRINCIPAL_INVESTIGATOR)
University of WashingtonSeattleWashington98104
Kristen Gonzalez-Farris
206-897-6797
Angela Hanson, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Miami, FL

Related Studies